Kitov Pharma Ltd (KTOV) Stock Price, Quote, News and Overview
NASDAQ:KTOV - Nasdaq -
KTOV Quote, Performance and Key Statistics
4.17
+0.09 (+2.21%)
The current stock price of KTOV is 4.17 null. In the past month the price increased by 2.71%. In the past year, price decreased by -45.12%.
About KTOV
Company Profile
Kitov Pharmaceuticals Holdings Ltd. is a pharmaceutical company which focused on the development of therapeutic candidates. The company's product candidate consists of KIT-302, is formulated for treatment of pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment for OA. Kitov Pharmaceuticals Holdings Ltd. is based in Jerusalem, Israel.
Company Info
Kitov Pharma Ltd
ONE AZRIELI CENTER ROUND TOWER 132 MENACHEM BEGIN ROAD
TEL AVIV L3 6701101
CEO: Isaac Israel
Phone: 972-3933-3121
Kitov Pharma Ltd / KTOV FAQ
What is the stock price of Kitov Pharma Ltd today?
The current stock price of KTOV is 4.17 null. The price increased by 2.21% in the last trading session.
What is the ticker symbol for Kitov Pharma Ltd stock?
The exchange symbol of Kitov Pharma Ltd is KTOV and it is listed on the Nasdaq exchange.
On which exchange is KTOV stock listed?
KTOV stock is listed on the Nasdaq exchange.
What is Kitov Pharma Ltd worth?
Kitov Pharma Ltd (KTOV) has a market capitalization of 65.57M null. This makes KTOV a Micro Cap stock.
What are the support and resistance levels for Kitov Pharma Ltd (KTOV) stock?
Kitov Pharma Ltd (KTOV) has a support level at 4.16 and a resistance level at 4.34. Check the full technical report for a detailed analysis of KTOV support and resistance levels.
Should I buy Kitov Pharma Ltd (KTOV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KTOV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KTOV, evaluating the profitability, health, valuation and growth aspects
- Kitov Pharma Ltd (KTOV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Kitov Pharma Ltd (KTOV) Sales and EPS estimates to see what analysts future expectations are.
- Kitov Pharma Ltd (KTOV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Kitov Pharma Ltd (KTOV) Insider and Institutional Ownership to learn about the owners and their transactions.
- Kitov Pharma Ltd (KTOV) Stock Chart to make your own analysis
- Kitov Pharma Ltd (KTOV) Latest news and press-releases to stay up to date.
Does Kitov Pharma Ltd (KTOV) stock pay dividends?
KTOV does not pay a dividend.
What is the Price/Earnings (PE) ratio of Kitov Pharma Ltd (KTOV)?
Kitov Pharma Ltd (KTOV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3).
KTOV Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to KTOV. When comparing the yearly performance of all stocks, KTOV is a bad performer in the overall market: 94.86% of all stocks are doing better.
KTOV Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to KTOV. KTOV may be in some trouble as it scores bad on both profitability and health.
KTOV Financial Highlights
Over the last trailing twelve months KTOV reported a non-GAAP Earnings per Share(EPS) of -3. The EPS increased by 18.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -585% | ||
| ROA | -6.82% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
KTOV Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to KTOV. The Buy consensus is the average rating of analysts ratings from 1 analysts.